Today: 29 April 2026
Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus
2 February 2026
1 min read

Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

New York, February 2, 2026, 15:14 EST — Regular session

  • Coherent shares climbed over 6% in afternoon trading, bouncing between $206 and $229.10.
  • The company will report fiscal second-quarter results after the close on Feb. 4.
  • A buyer confirmed it has finalized the acquisition of Coherent’s Tools for Materials Processing business.

Coherent shares surged over 6% Monday, last seen climbing 6.4% to $225.69 in afternoon trading. The stock swung between $206 and $229.10 earlier in the session.

Traders are snapping up shares ahead of the company’s quarterly results due later this week, seen as a crucial indicator of demand for optics in AI data centers.

Investors are also digesting news from Switzerland, where Bystronic announced it finalized the acquisition of Coherent’s Tools for Materials Processing business.

Coherent will release its quarterly results for the period ending Dec. 31 after the market closes on Feb. 4, with a webcast scheduled for 4:30 p.m. ET, Zacks Investment Research said in a note shared by Nasdaq. Analysts expect earnings of $1.22 per share on $1.6 billion in revenue. The report also highlighted growing competition in silicon carbide components from Wolfspeed and ON Semiconductor.

Bystronic said the deal expands its laser portfolio into medical technology, semiconductors, and other sectors, and it plans to relaunch the Rofin brand as part of a new business unit. “We warmly welcome all customers, partners, and colleagues,” CEO Domenico Iacovelli said in a statement. Zawya

Coherent reported in October that its tools unit had roughly 400 employees and brought in around $100 million in annual sales. The company plans to use the proceeds from the sale to pay down debt. CEO Jim Anderson described the deal as part of a portfolio review aimed at focusing on core growth markets and products.

The company produces lasers, transceivers, and various optical and optoelectronic devices serving communications, industrial, and electronics sectors, according to an annual filing.

The wide intraday swings highlight jittery positioning ahead of the earnings release. Options—contracts allowing investors to buy or sell shares at predetermined prices—were implying roughly a 15% move by the Feb. 6 expiry, per OptionSlam.

Investors on the call will focus on datacenter and communications demand, watching closely to see if production ramps are on track. Insights into pricing trends or customer inventory levels could also move the needle.

Yet the surge leaves almost no margin for error. Any weaker guidance or margin squeeze from added capacity could swiftly send the rally into reverse.

Coherent’s earnings drop after the bell on Feb. 4 will be the next key moment, along with the guidance it provides during the subsequent call.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:59 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Previous Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop